UNICA IRIS Institutional Research Information System

PISANU, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 154.019
NA - Nord America 8.621
AS - Asia 4.665
SA - Sud America 1.008
AF - Africa 174
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 1
Totale 168.529
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 151.633
US - Stati Uniti d'America 8.384
SG - Singapore 1.847
CN - Cina 1.345
BR - Brasile 769
SE - Svezia 542
VN - Vietnam 509
DE - Germania 336
GB - Regno Unito 326
FR - Francia 230
FI - Finlandia 228
HK - Hong Kong 205
NL - Olanda 187
IN - India 137
UA - Ucraina 135
CA - Canada 132
AR - Argentina 92
KR - Corea 80
BD - Bangladesh 79
ES - Italia 77
JP - Giappone 67
MX - Messico 67
AT - Austria 53
IQ - Iraq 53
PL - Polonia 48
TR - Turchia 47
ZA - Sudafrica 47
MA - Marocco 45
EC - Ecuador 42
AU - Australia 37
BE - Belgio 36
RU - Federazione Russa 36
CO - Colombia 29
PK - Pakistan 29
ID - Indonesia 24
NO - Norvegia 24
PH - Filippine 24
SA - Arabia Saudita 23
VE - Venezuela 23
IE - Irlanda 22
UZ - Uzbekistan 22
IR - Iran 21
CL - Cile 19
MY - Malesia 18
CZ - Repubblica Ceca 17
DK - Danimarca 17
JO - Giordania 17
EG - Egitto 14
KE - Kenya 14
IL - Israele 13
KZ - Kazakistan 13
PY - Paraguay 13
TW - Taiwan 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
PT - Portogallo 11
TN - Tunisia 11
DZ - Algeria 10
AZ - Azerbaigian 9
LT - Lituania 9
OM - Oman 7
PS - Palestinian Territory 7
BO - Bolivia 6
JM - Giamaica 6
KG - Kirghizistan 6
PA - Panama 6
PE - Perù 6
SN - Senegal 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
GE - Georgia 5
MD - Moldavia 5
NI - Nicaragua 5
NP - Nepal 5
QA - Qatar 5
RS - Serbia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
RO - Romania 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
IS - Islanda 2
LV - Lettonia 2
Totale 168.494
Salva come PNG Salva come JPEG
Città #
Cagliari 146.646
Uta 4.411
Singapore 977
Ashburn 936
Dallas 777
Fairfield 721
San Jose 606
Chandler 379
Woodbridge 340
Boardman 334
Houston 321
New York 309
Seattle 288
Nyköping 260
Beijing 247
Los Angeles 229
Cambridge 221
Wilmington 221
Ann Arbor 177
Hong Kong 177
The Dalles 161
Council Bluffs 153
Santa Clara 150
Helsinki 146
Ho Chi Minh City 144
Hefei 124
Shanghai 119
Lauterbourg 112
Boston 107
Hanoi 106
Dearborn 88
São Paulo 81
Seoul 75
Jacksonville 70
Munich 70
Buffalo 64
Rome 62
Cardiff 61
Dong Ket 60
Tokyo 56
Nieuwegein 54
Orem 54
Frankfurt am Main 50
Chicago 49
Montreal 46
Nuremberg 44
Atlanta 41
London 41
San Diego 39
Warsaw 39
Lappeenranta 38
Redondo Beach 38
Johannesburg 36
Nanjing 35
Amsterdam 32
Brussels 32
Denver 32
Vienna 30
Casablanca 29
Chennai 29
Poplar 29
Brooklyn 28
Stockholm 28
Milan 27
Redwood City 27
Guangzhou 26
Rio de Janeiro 25
Mexico City 24
San Francisco 24
Toronto 24
Da Nang 22
Oslo 22
Phoenix 22
Tianjin 22
Turku 22
Norwalk 21
Haiphong 19
Changsha 18
Tashkent 18
Baghdad 17
Manchester 17
Nanchang 17
Rotterdam 17
Belo Horizonte 16
Guayaquil 16
Shenyang 16
Shenzhen 16
Ankara 15
Aurora 15
Quito 15
Swansea 15
Amman 14
Biên Hòa 14
Brasília 14
City of London 14
Dublin 14
Hangzhou 14
Pune 14
Jiaxing 13
Paris 13
Totale 162.138
Salva come PNG Salva come JPEG
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.363
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.262
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein 3.688
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.619
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.567
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.505
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.423
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.138
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.048
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.042
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.012
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.006
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.986
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.889
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.881
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.822
Involvement of core clock genes in lithium response 2.813
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.701
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.676
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.671
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.665
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.645
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.594
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis 2.538
Prediction of Lithium Response using Clinical Data 2.486
High leptin levels are associated with migraine with aura 2.460
Pharmacogenomics of bipolar disorder 2.398
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.375
Lithium pharmacogenetics: Where do we stand? 2.284
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.229
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.186
null 2.132
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 2.106
Characterisation of age and polarity at onset in bipolar disorder 2.022
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.003
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica 1.987
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.933
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.886
Lithium pharmacogenetics 1.858
A genetic risk score is differentially associated with migraine with and without aura 1.846
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.721
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.673
Leukocyte telomere length is reduced in patients with major depressive disorder 1.657
Prediction of lithium response using genomic data 1.645
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.624
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.606
null 1.572
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.517
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.503
PharmacoloGenius: Development of a mobile application to engage in pharmacology 1.461
Telomere length in bipolar disorder and lithium response 1.308
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.264
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.246
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.227
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.194
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants 1.187
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.185
Assessment of the pharmacogenomics educational environment in southeast europe 1.179
null 1.156
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.013
A genome-wide association study of antidepressant-induced mania 983
Gender Differences among Sardinians with Alcohol Use Disorder 944
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 824
Sex differences in alcohol use disorder 819
The Xs and Y response to opioids in acute and chronic pain 798
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 779
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis 777
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 774
Sex differences in substance use disorders: focus on side effects 773
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 767
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 756
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank 732
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 726
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 716
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 714
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 707
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder 704
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 674
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 656
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 654
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 650
Effect of Lithium on gene expression modulation 648
Genetic and Epigenetic Markers of Lithium Response 642
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 637
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 633
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders 589
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 577
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study 552
An analysis-ready and quality controlled resource for pediatric brain white-matter research 535
Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014 501
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 488
Towards precision medicine in psychiatry: investigating the contribution of cellular aging, pleiotropy and gender differences in psychiatric disorders and pharmacological response 483
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis 481
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 467
New insights into the genetic etiology of Alzheimer's disease and related dementias 460
Plasma stearoyl-coA desaturase activity indices and bile acid concentrations after a low-fat meal: Association with a genetic variant in the FTO gene 449
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept 442
NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition 419
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 413
Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28) 392
Totale 162.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 215.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 215.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.100 0 0 0 0 0 0 0 0 0 2.741 2.720 1.639
2021/202210.999 1.450 652 510 1.016 990 707 574 508 1.262 1.197 1.204 929
2022/202316.802 960 2.313 2.452 1.529 1.304 1.617 848 1.042 1.211 1.248 1.470 808
2023/202416.375 770 611 612 1.037 1.419 2.565 2.311 1.197 835 1.075 1.958 1.985
2024/202538.024 10.322 11.152 3.920 3.963 2.061 2.347 2.445 163 396 410 319 526
2025/202611.067 940 614 1.489 1.289 1.019 879 1.742 1.012 754 1.329 0 0
Totale 169.141